Cabronero, J. A, et al.: In Vivo Quantitative Susceptibility Mapping (QSM) in Alzheimer's Disease. PLOS ONE, 8(11), e81093, 2013.
The National Lung Screening Trial Research Team: Reduced lung-cancer morality with low-dose computed tomographic screening. N. Eng. J. Med., 365, 395-409, 2011.